BlogFile: Dendreon Corporation (DNDN)
BioHealth Investor.com
COMPANY BlogFILE
updated: May 15, 2007
DENDREON CORPORATION
3005 First Avenue
Seattle, WA 98121
Phone: (206) 256-4545
Fax: (206) 256-0571
www.dendreon.com
Investor/Public Relations
(206) 829-1500
ir@dendreon.com
COMPANY DESCRIPTION
Dendreon Corporation is a Seattle-based biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
Through innovative science and technology, is striving to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile.
BUSINESS INFORMATION
Public company
Ticker: DNDN
Market: NASDAQ
Industry: Biotechnology
LATEST BLOG COMMENTARY
Dendreon, the Day That Could Have Been and What to Expect Now
24/7 Wall St.
May 15, 2007
Why Did the FDA Decide to Flunk Dendreon’s Provenge?
SeekingAlpha
May 14, 2007
Dendreon – Is Provenge Snake Oil or Cure?
The Disciplined Investor
May 12, 2007
DNDN… is it Over?
Echo To All
May 12, 2007
Rantasorous Rx
Health Business Blog
May 11, 2007
Comments From Dendreon’s Conference Call (May 10, 2007)
24/7 Wall St.
May 10, 2007
Dendreon Gets Complete Response Letter
Eye On FDA
May 09, 2007
Dendreon Nailed by FDA
24/7 Wall St.
May 09, 2007
Dendreon: The Short Story
SeekingAlpha
May 09, 2007
Dendreon: The Next Genentech/Amgen?
SeekingAlpha
May 04, 2007
Source: BioHealth Investor.com
____________________
Comments
One Response to “BlogFile: Dendreon Corporation (DNDN)”
Leave a Reply
I have an iPhone wit 3.1 software and I was wondering if anybody knows how to sync it onto different computers so I could get more music without having the music i already have replaced. I’m also tryin to stay away from jail breaking.
best forex software unlock iphone